Dr. Barbara Lawrenz

• Global Clinical Scholars Research Training (GCSRT) Certificate Program, Harvard Medical School. Boston, USA, 2020-2021.
• Habilitation thesis: Fertility preservation before cytotoxic therapy in young girls, adolescents, and premenopausal women. Obtaining the designation lecturer ("Privatdozentin") Teaching license of the University of Tübingen for Obstetrics and Gynecology
• Certificate for University Teaching and Learning in Medicine
• Specialization in gynecological endocrinology and reproductive medicine
• Specialization in obstetrics and perinatal medicine
• Specialist in gynecology and obstetrics
• Doctoral dissertation: "Determination of Protein C with capillary methods" Grade: "cum laude”
• Study of medicine in Berlin and Giessen, Germany

•    Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay
•    Inter-assay variation and reproducibility of progesterone measurements during ovarian stimulation for IVF
•    The effects of cancer therapy on women’s fertility: what do we know now?
•    Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing
•    Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population?
•    Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation – a retrospective analysis of the Ensure data
•    Luteal phase serum progesterone levels after GnRH-agonist trigger - how low is still high enough for an ongoing pregnancy?
•    Premature progesterone elevation: targets and rescue strategies
•    Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes
•    Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
•    Premature progesterone rise in ART-cycles
•    What Drives Embryo Development? Chromosomal Normality or Mitochondria?
•    Individual luteolysis pattern after GnRH agonist trigger for final oocyte maturation
•    Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity
•    Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols
•    Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles
•    Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and “freeze all policy" without luteal phase support: a report of four cases
•    A non -receptive ERA test result in an HRT cycle may not be replicable in a natural cycle: A case report
•    Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
•    Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist
•    Reply: Careful and expert interpretation of PGT-A data can resolve the mosaicism dilemma
•    Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
•    The importance of embryo quality and day of biopsy in frozen single euploid blastocyst transfer cycles
•    Anti-Müllerian Hormone as a Quantitative and Qualitative Marker of Euploid Blastocysts.
•    ESHRE 2019: The Depth of Embryo Replacement Inside the Uterine Cavity Influences Pregnancy and Implantation Rates in IVF
•    Is There A Relationship Between Mitochondrial DNA Content And Abortion Rate In Patients Undergoing Single Euploid Frozen Embryo Transfer?
•    Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study.
•    IS PARENTAL CONSANGUINITY ASSOCIATED WITH LOW OVARIAN RESERVE AND HIGHER RATE OF ANEUPLOIDIES?
•    Mitochondrial DNA content of cleavage stage embryos and their relation to preimplantation development and aneuploidy
•    Cleavage stage mitochondrial DNA is correlated with preimplantation human embryo development and ploidy status
•    mtDNA dynamics between cleavage-stage embryos and blastocysts
•    The clinicians ́ dilemma with mosaicism—an insight from inner cell mass biopsies
•    Anti-Müllerian Hormone (AMH) as a quantitative and qualitative marker of euploid blastocysts.
•    Anti-Müllerian Hormone (AMH) is an independent marker for oocyte survival post vitrification.
•    Individualized luteal phase support
•    A non -receptive ERA test result in an HRT cycle may notbe replicable in a natural cycle: A case report
•    Ethnical and sociocultural differences causing infertility are poorly understood—insights from the Arabian perspective
•    Inhibin A—A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI
•    Is a naturally reduced antimullerian hormone at a young age linked to an increased risk of cancer development?
•    Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study
•    ANTI-MULLERIAN HORMONE IS AN INDEPENDENT MARKER FOR OOCYTE SURVIVAL POST-VITRIFICATION
•    The ART of frozen embryo transfer: back to nature!
•    The search must go on - for patients with recurrent pregnancy loss
•    Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A)
•    Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population Does blastocyst mitochondrial DNA content affect miscarriage rate in patients undergoing single euploid frozen embryo transfer?Gibt es optimale Serumprogesteronwerte in In-vitro-Fertilisations- und Kryozyklen?